Conjugate Vaccine Market updates, demand analysis and expected growth forecast
Conjugate Vaccine Market |
Conjugate
vaccines are those that contain a bacterial capsule polysaccharide or an
antigen that has been attached or conjugated to a protein. This protein plays
an important role in increasing the polysaccharide's immunogenicity. These
vaccines are primarily used to immunize infants and children against Hib
bacteria, H. influenza, Streptococcus pneumonia, and Neisseria meningitides.
The rise in the use of conjugate vaccines for adults, the increase in the number
of regulatory approvals for conjugate vaccines, the rise in the prevalence of
diseases caused by microorganisms such as Streptococcus pneumonia and Neisseria
meningitides, and technological advancements all contribute significantly to
the market's growth. In contrast, the inaccessibility of vaccines in remote
areas, as well as the complex production procedure of conjugate vaccines, limit the market growth.
The
growing use of conjugate vaccines for adults, as well as the increasing number
of regulatory approvals for conjugate vaccines, are expected to drive market
growth.
The Global Conjugate Vaccine
Market offers a comprehensive analysis. The provides an in-depth examination of
key segments, trends, drivers, restraints, the competitive landscape, and
factors that are important in the market.
Certain
restraints and challenges will impede the overall growth of the Conjugate Vaccine market.
The complex manufacturing process of conjugate vaccines, as well as the
scarcity of these vaccines in remote areas, as well as recent incidents
involving fraud and malpractice by top vaccine manufacturers. For example, in
July 2018, Changchun Chan sheng Life Sciences Limited, China's second-largest
vaccine manufacturer, was found guilty of falsifying its manufacturing records
and faced legal action. COVID-19 is an unprecedented global public health
emergency that has impacted nearly every industry, and its long-term effects
are expected to have an impact on industry growth during the forecast period.
Sanofi S.A., Pfizer, Inc., Merck & Co.,
Inc., GlaxoSmithKline plc, Bharat Biotech, Serum Institute of India Pvt. Ltd.,
Biological E. Limited, and Bio-Med are key players in the global conjugate
vaccine market.
Comments
Post a Comment